BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7518716)

  • 1. Proliferation and activation of vascular endothelial cells in epiretinal membranes from patients with proliferative diabetic retinopathy. An immunohistochemistry and clinical study.
    Tang S; Le-Ruppert KC; Gabel VP
    Ger J Ophthalmol; 1994 May; 3(3):131-6. PubMed ID: 7518716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patients with proliferative diabetic retinopathy].
    Augustin AJ; Keller A; Koch F; Jurklies B; Dick B
    Klin Monbl Augenheilkd; 2001 Feb; 218(2):89-94. PubMed ID: 11258131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM; Polak BC; Reichert-Thoen JW; de Vries-Knoppert WA; van Hinsbergh VW; Tangelder GJ
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
    Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Uchita M; Matsuzaki T; Takayama M; Shinmura K; Yamada M
    Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
    Merlak M; Kovacević D; Balog T; Marotti T; Misljenović T; Mikulicić M; Dekaris I
    Coll Antropol; 2008 Oct; 32 Suppl 2():39-43. PubMed ID: 19138004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on proliferating vascular endothelial cells in diabetic epiretinal membranes.
    Tang S; Le-Ruppert KC; Gabel VP
    Br J Ophthalmol; 1994 May; 78(5):370-6. PubMed ID: 7517695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
    Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
    Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
    Mathews MK; Merges C; McLeod DS; Lutty GA
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
    Castellon R; Caballero S; Hamdi HK; Atilano SR; Aoki AM; Tarnuzzer RW; Kenney MC; Grant MB; Ljubimov AV
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in retinal neovascular tissue and vitreous humour in patients with type 1 and type 2 diabetes.
    Kinnunen K; Puustjärvi T; Teräsvirta M; Nurmenniemi P; Heikura T; Laidinen S; Paavonen T; Uusitalo H; Ylä-Herttuala S
    Br J Ophthalmol; 2009 Aug; 93(8):1109-15. PubMed ID: 19304585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
    Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
    Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of cellular adhesion molecules (ICAM-1, VCAM-1) and VEGF in fibrovascular membranes of patients with proliferative diabetic retinopathy: preliminary study.
    Khalfaoui T; Lizard G; Beltaief O; Colin D; Ben Hamida J; Errais K; Ammous I; Zbiba W; Tounsi L; Zhioua R; Anane R; Ouertani-Meddeb A
    Pathol Biol (Paris); 2009; 57(7-8):513-7. PubMed ID: 18834676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells.
    Hirata C; Nakano K; Nakamura N; Kitagawa Y; Shigeta H; Hasegawa G; Ogata M; Ikeda T; Sawa H; Nakamura K; Ienaga K; Obayashi H; Kondo M
    Biochem Biophys Res Commun; 1997 Jul; 236(3):712-5. PubMed ID: 9245719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.